347 related articles for article (PubMed ID: 31755117)
1. High-throughput lipidomics analysis to discover lipid biomarkers and profiles as potential targets for evaluating efficacy of Kai-Xin-San against APP/PS1 transgenic mice based on UPLC-Q/TOF-MS.
Zhang AH; Ma ZM; Kong L; Gao HL; Sun H; Wang XQ; Yu JB; Han Y; Yan GL; Wang XJ
Biomed Chromatogr; 2020 Feb; 34(2):e4724. PubMed ID: 31755117
[TBL] [Abstract][Full Text] [Related]
2. High-throughput lipidomics characterize key lipid molecules as potential therapeutic targets of Kaixinsan protects against Alzheimer's disease in APP/PS1 transgenic mice.
Gao HL; Zhang AH; Yu JB; Sun H; Kong L; Wang XQ; Yan GL; Liu L; Wang XJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():286-295. PubMed ID: 29933222
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572
[TBL] [Abstract][Full Text] [Related]
4. Anti-depressive effects of Kai-Xin-San on lipid metabolism in depressed patients and CUMS rats using metabolomic analysis.
Zhou X; Wang J; Lu Y; Chen C; Hu Y; Liu P; Dong X
J Ethnopharmacol; 2020 Apr; 252():112615. PubMed ID: 31991203
[TBL] [Abstract][Full Text] [Related]
5. Rapid discovery of quality-markers from Kaixin San using chinmedomics analysis approach.
Wang XJ; Zhang AH; Kong L; Yu JB; Gao HL; Liu ZD; Sun H
Phytomedicine; 2019 Feb; 54():371-381. PubMed ID: 30322673
[TBL] [Abstract][Full Text] [Related]
6. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
[TBL] [Abstract][Full Text] [Related]
7. Serum lipidomics study reveals protective effects of Rhodiola crenulata extract on Alzheimer's disease rats.
Sun W; Liu C; Zhou X; Li X; Chu X; Wang X; Han F
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1158():122346. PubMed ID: 32882532
[TBL] [Abstract][Full Text] [Related]
8. Kai-Xin-San Improves Cognitive Impairment via Wnt/β-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice.
Xu YM; Lu FM; Xu HC; Zhang J; Hei SY; Qiu YH; Cai YF; Zhang SJ; Zhao M
Rejuvenation Res; 2023 Jun; 26(3):105-115. PubMed ID: 37073462
[TBL] [Abstract][Full Text] [Related]
9. Untargeted lipidomics reveals progression of early Alzheimer's disease in APP/PS1 transgenic mice.
Zhang X; Liu W; Zan J; Wu C; Tan W
Sci Rep; 2020 Sep; 10(1):14509. PubMed ID: 32884056
[TBL] [Abstract][Full Text] [Related]
10. Rhodiola crenulata protects against Alzheimer's disease in rats: A brain lipidomics study by Fourier-transform ion cyclotron resonance mass spectrometry coupled with high-performance reversed-phase liquid chromatography and hydrophilic interaction liquid chromatography.
Sun W; Liu C; Wang Y; Zhou X; Sui W; Zhang Y; Zhang Q; Han J; Li X; Han F
Rapid Commun Mass Spectrom; 2021 Jan; 35(2):e8969. PubMed ID: 33047398
[TBL] [Abstract][Full Text] [Related]
11. Kai-Xin-San Inhibits Tau Pathology and Neuronal Apoptosis in Aged SAMP8 Mice.
Jiao YN; Zhang JS; Qiao WJ; Tian SY; Wang YB; Wang CY; Zhang YH; Zhang Q; Li W; Min DY; Wang ZY
Mol Neurobiol; 2022 May; 59(5):3294-3309. PubMed ID: 35303280
[TBL] [Abstract][Full Text] [Related]
12. Global identification and determination of the major constituents in Kai-Xin-San by ultra-performance liquid chromatography-quadrupole-Orbitrap mass spectrometry and gas chromatography-mass spectrometry.
Lin R; Yin J; Wu M; Ding H; Han L; Yang W; Song X; Bie S; Wang C; He Y; Yu H; Li Z
J Pharm Biomed Anal; 2021 Nov; 206():114385. PubMed ID: 34597841
[TBL] [Abstract][Full Text] [Related]
13. Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease.
Yi P; Zhang Z; Huang S; Huang J; Peng W; Yang J
Pharm Biol; 2020 Dec; 58(1):932-943. PubMed ID: 32956608
[TBL] [Abstract][Full Text] [Related]
14. Lipidomics study of plasma phospholipid metabolism in early type 2 diabetes rats with ancient prescription Huang-Qi-San intervention by UPLC/Q-TOF-MS and correlation coefficient.
Wu X; Zhu JC; Zhang Y; Li WM; Rong XL; Feng YF
Chem Biol Interact; 2016 Aug; 256():71-84. PubMed ID: 27369808
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant-like effect of the extracted of Kai Xin San, a traditional Chinese herbal prescription, is explained by modulation of the central monoaminergic neurotransmitter system in mouse.
Zhou XJ; Liu M; Yan JJ; Cao Y; Liu P
J Ethnopharmacol; 2012 Jan; 139(2):422-8. PubMed ID: 22138350
[TBL] [Abstract][Full Text] [Related]
16. UHPLC Q-Exactive MS-based spleen metabolomics and lipidomics to explore the effect mechanisms of Danggui Buxue Decoction in anemia mice.
Liu Y; Li X; Li A; Li K; Qin X
J Pharm Biomed Anal; 2020 Jun; 185():113234. PubMed ID: 32171146
[TBL] [Abstract][Full Text] [Related]
17. Exploring lipid biomarkers of coronary heart disease for elucidating the biological effects of gelanxinning capsule by lipidomics method based on LC-MS.
Gao X; Hu XH; Zhang Q; Wang XJ; Wen XH; Wang Y; Zhang YX; Sun WJ
Biomed Chromatogr; 2021 Jul; 35(7):e5091. PubMed ID: 33618435
[TBL] [Abstract][Full Text] [Related]
18. Hippocampus Proteomics and Brain Lipidomics Reveal Network Dysfunction and Lipid Molecular Abnormalities in APP/PS1 Mouse Model of Alzheimer's Disease.
Zhang X; Liu W; Cao Y; Tan W
J Proteome Res; 2020 Aug; 19(8):3427-3437. PubMed ID: 32510958
[TBL] [Abstract][Full Text] [Related]
19. Identification and determination of the major constituents in Kai-Xin-San by UPLC-Q/TOF MS and UFLC-MS/MS method.
Lv C; He B; Sui Z; Li Q; Bi K
J Mass Spectrom; 2016 Jul; 51(7):479-90. PubMed ID: 27434806
[TBL] [Abstract][Full Text] [Related]
20. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
